随着CAR-T细胞疗法在实体瘤领域取得进展,监管繁文缛节阻碍发展步伐。
As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
生物技术与制药领域的最新动态
As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
Organism-wide cellular dynamics and epigenomic remodeling in mammalian aging | Science
A cellular basis for the mammalian nocturnal-diurnal switch | Science
Reconstitution of sex determination and the testicular niche using mouse pluripotent stem cells | Science
A Live-Cell NanoBRET Assay Shines Light on Toxic RNA–Protein Interactions in Myotonic Dystrophy
Whole-organ and whole-body 3D atlases enable cellome-wide profiling
Nuclear speckles enable processing of RNA from GC-rich isochores
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis
The MicrobeAtlas database: Global trends and insights into Earth’s microbial ecosystems
Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
Editing strigolactone hormone receptor for robust antiviral silencing in rice
A regulatory network promotes apoplastic alkalinization to prime plant immunity in tissues distal to site of infection
Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition
Vir climbs on Astellas deal, study results for ‘masked’ T cell engager
Astellas and Vir in $1.3B deal for CD3 T-cell engager
Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies
Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking
Single Cell Multiomics Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com
Gilead brings Arcellx fully under the fold